A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Ginkgo Biloba Extract | Ginkgo biloba extract is prepared from the leaves of Maidenhair Tree after Adiantum, which is a unique species of tree with no close living relatives. Ginkgo biloba leaf extract is used for the treatment of numerous conditions, many of which are under scientific investigation. The most powerful effect of ginkgo biloba extract is on the circulating system. Ginkgo biloba extract can be used to treat respiratory problems such as asthma and bronchitis. Group: Others. Mole weight: 408.4. Ginkgo Biloba Extract; Ginkgo Biloba Linn. Cat No: EXTC-009. |  |
| Ginkgo Biloba Flavonoids Mix | 100 ?g/mL each component in methanol, ampule of 1.0 mL, certified reference material. Group: Herbal medicinal products standards. |  |
| Ginkgo Biloba Leaf Extract | 1.Ginkgo biloba leaf extract is an effective anti-oxidant.2.Ginkgo biloba leaf extract can be used for anti-cancer and preventing cancer.3.Ginkgo biloba leaf extract can promot cerebral blood circulation and cellular metabolism.4.Ginkgo biloba leaf extract has the function of lowering blood pressure and high blood fat.5.Ginkgo biloba leaf extract is tonifying kidney and nourishing brain, whitening and anti-wrinkle.6.Ginkgo biloba leaf extract is effective on dilating blood vessels, promoting blood circulation and enhancing immunity. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Ginkgo Biloba Leaf Extract. Product Category: Material of cosmetics. Appearance: Yellow brown fine powder. CAS No. 90045-36-6. Product ID: ACM90045366. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Ginkgo Biloba Leaf Powder & P.E. 4:1 | Ginkgo Biloba Leaf Powder & P.E. 4:1. |  CA, FL & NJ |
| Ginkgo Biloba Terpene Lactones Mix | 100 ?g/mL each component in acetonitrile, ampule of 1.0 mL, certified reference material. Group: Herbal medicinal products standards. | |
| Ginkgolic Acid | Ginkgolic Acid is a natural compound that inhibits SUMOylation with an IC 50 of 3.0 μM in in vitro assay. Uses: Scientific research. Group: Natural products. Alternative Names: Ginkgolic acid (15:1); Ginkgolic acid I; Romanicardic acid. CAS No. 22910-60-7. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-N0077. |  |
| Ginkgolic Acid | Ginkgolic Acid. CAS No: 22910-60-7 |  Sarchem Laboratories New Jersey NJ |
| Ginkgolic acid 15:1 | Ginkgolic acid 15:1. Group: Biochemicals. CAS No. 22910-60-7. Pack Sizes: 5mg. US Biological Life Sciences. |  Worldwide |
| Ginkgolic Acid (15:1) - CAS 22910-60-7 | A cell-permeable anacardic acid analog that inhibits protein SUMO. Group: Fluorescence/luminescence spectroscopy. | |
| Ginkgolic acid 17:1 | Ginkgolic acid 17:1. Group: Biochemicals. CAS No. 111047-30-4. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Ginkgolic acid (C13:0) | Ginkgolic acid (C13:0). Group: Biochemicals. Grades: Highly Purified. CAS No. 20261-38-5. Pack Sizes: 25mg, 50mg, 100mg, 250mg, 500mg. Molecular Formula: C20H32O3. US Biological Life Sciences. | Worldwide |
| Ginkgolic Acid (C13:0) | Ginkgolic Acid (C13:0) is a natural anticariogenic agent in that it exhibits antimicrobial activity against S. Uses: Scientific research. Group: Natural products. Alternative Names: Ginkgolic acid (13:0); Ginkgoneolic Acid; 6-Tridecylsalicylic acid. CAS No. 20261-38-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N0078. | |
| Ginkgolic Acid C13-0 | Ginkgolic Acid C13-0. Group: Biochemicals. Alternative Names: Ginkgolic Acid C13:0. Grades: Plant Grade. CAS No. 20261-38-5. Pack Sizes: 10mg. Molecular Formula: C20H32O3, Molecular Weight: 320.466. US Biological Life Sciences. | Worldwide |
| ginkgolic acid (C15:1) | ginkgolic acid (C15:1). Group: Biochemicals. Grades: Highly Purified. CAS No. 22910-60-7. Pack Sizes: 25mg, 50mg, 100mg, 250mg, 500mg. Molecular Formula: C22H34O3. US Biological Life Sciences. | Worldwide |
| Ginkgolic Acid C15-1 | Ginkgolic Acid C15-1. Group: Biochemicals. Alternative Names: Ginkgolic Acid C15:1; Ginkgoic acid; Ginkgolic acid; Romanicardic acid; (15:1)-Anacardic acid; Ana B. Grades: Plant Grade. CAS No. 22910-60-7. Pack Sizes: 20mg. Molecular Formula: C22H34O3, Molecular Weight: 346.504. US Biological Life Sciences. | Worldwide |
| Ginkgolic acid (C17:1) | Ginkgolic acid (C17:1). Group: Biochemicals. Grades: Highly Purified. CAS No. 111047-30-4. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C24H38O3. US Biological Life Sciences. | Worldwide |
| Ginkgolic acid C17:1 | Ginkgolic acid C17:1 is a fatty acid synthase ( FAS ) inhibitor with an IC 50 of 10.5 μM. Ginkgolic acid C17:1 shows anti-tumor activity by inhibiting the phosphorylation of STAT3 and inducing apoptosis. Ginkgolic acid C17:1 can block the interaction between S-RBD and ACE2 , and has anti- SARS-CoV-2-S pseudovirus activity. Ginkgolic acid C17:1 inhibits the biofilm formation of enterohemorrhagic Escherichia coli and Staphylococcus aureus [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Natural products. CAS No. 111047-30-4. Pack Sizes: 5 mg; 10 mg. Product ID: HY-N2116. | |
| Ginkgolic Acid C17-1 | Ginkgolic Acid C17-1. Group: Biochemicals. Alternative Names: Ginkgolic Acid C17:1. Grades: Plant Grade. CAS No. 111047-30-4. Pack Sizes: 10mg. Molecular Formula: C24H38O3, Molecular Weight: 374.557. US Biological Life Sciences. | Worldwide |
| Ginkgolic Acids | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardseuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. Alternative Names: Ginkgolic Acids. | |
| Ginkgolide A | Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Uses: Scientific research. Group: Natural products. Alternative Names: BN-52020. CAS No. 15291-75-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-B0355. | |
| Ginkgolide A | Ginkgolide A is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist with a Ki of 14.5 μM. Synonyms: (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-3-(1,1-Dimethylethyl)hexahydro-4,7b-dihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione; 9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)hexahydro-4,7b-dihydroxy-8-methyl-, [1R-(1α,3β,3aS*,4β,6aα,7aα,7bα,8α,10aα,11aS*)]-; [1R-(1α,3β,3aS*,4β,6aα,7aα,7bα,8α,10aα,11aS*)]-3-(1,1-Dimethylethyl)hexahydro-4,7b-dihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione; Bilobalide A; BN 52020. Grade: >98%. CAS No. 15291-75-5. Molecular formula: C20H24O9. Mole weight: 408.40. |  |
| Ginkgolide A | Family of bioactive terpenes treating cardiovascular and cerebrovascular diseases. Specific platelet activating factor (PAF) antagonists. Group: Biochemicals. Alternative Names: (1R, 3S, 3aS, 4R, 6aR, 7aR, 7bR, 8S, 10aS, 11aS) -3- (1, 1-Dimethylethyl) hexahydro-4, 7b-dihydroxy-8-methyl-9H-1, 7a- (epoxymethano) -1H, 6aH-cyclopenta[c]furo[2, 3-b]furo[3', 2': 3, 4]cyclopenta[1, 2-d]furan-5, 9, 12 (4H) -trione; BN 52020. Grades: Highly Purified. CAS No. 15291-75-5. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Ginkgolide A from Ginkgo biloba leaves | analytical standard, ?90% (HPLC). Group: Herbal medicinal products standards. | |
| Ginkgolide B | Ginkgolide B (BN-52021), a terpene lactone, is a potent platelet activating factor antagonist. Ginkgolide B protects endothelial cells via the activation of PXR from injuries induced by xeno- and endobiotics. Ginkgolide B can pass through the brain-blood barrier. Ginkgolide B has anti-oxidant, anti-inflammatory, anti-tumor, and anti- apoptotic activity. Ginkgolide B has marked neuroprotective effects against ischemia-induced impairments [1] [2]. Uses: Scientific research. Group: Natural products. Alternative Names: BN-52021. CAS No. 15291-77-7. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-N0784. | |
| Ginkgolide B | Family of bioactive terpenes treating cardiovascular and cerebrovascular diseases. Specific platelet activating factor (PAF) antagonists. Group: Biochemicals. Alternative Names: (1R, 3S, 3aS, 4R, 6aR, 7aR, 7bR, 8S, 10aS, 11R, 11aR) -3- (1, 1-Dimethylethyl) hexahydro-4, 7b, 11-trihydroxy-8-methyl-9H-1, 7a- (epoxymethano) -1H, 6aH-cyclopenta[c]furo[2, 3-b]furo[3', 2': 3, 4]cyclopenta[1, 2-d]furan-5, 9, 12 (4H) -trione; BN 52021. Grades: Highly Purified. CAS No. 15291-77-7. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Ginkgolide B | Ginkgolide B (BN-52021), an important active terpenoid from Ginkgo biloba leaves, is reported to increase cell viability and decrease cell apoptosis.IC50 value:Target:In vitro: Ginkgolide B (0.2 or 0.4 μg/ml) was added to the culture medium in vitro led to increases in cell viability and decreases in the number of hippocampal cells undergoing AAPH-induced apoptosis. Ginkgolide B caused a dose-related protection against dysrhythmias; the antiarrhythmic effect of ginkgolide B was comparable to that of diltiazem and superior to the activity of metoprolol. Ginkgolide B can presumably prevent the re-entry mechanism involved in the development of ischemia-induced rhythm disturbances.In vivo: Oral administration of ginkgolide B (2 mg/kg/day, p.o.) caused a significant increase in cell viability and a highly significant decrease in the numbers of both spontaneously occurring and AAPH-induced apoptoses. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 7-Deoxyginkgolide C. Product Category: Inhibitors. Appearance: White powder. CAS No. 15291-77-7. Molecular formula: C20H24O10. Mole weight: 424.4. Purity: 0.98. IUPACName: (1R,3R,6R,7S,8S,10R,11R,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione. Canonical SMILES: C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C) | |
| Ginkgolide B | Ginkgolide B is a PAFR antagonist with an IC50 of 3.6 μM. Ginkgolide B is a bioactive diterpenoid trilactone derived from Ginkgo biloba leaves, known for its potent platelet-activating factor (PAF) antagonism. It has a complex structure with multiple chiral centers and exhibits significant neuroprotective and cerebrovascular benefits. These properties make it a promising candidate for treating neurodegenerative diseases, inflammation, and conditions related to cerebral blood flow. Uses: Fibrinolytic agents. Synonyms: (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-Dimethylethyl)hexahydro-4,7b,11-trihydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione; 5H-Dicyclopenta[b,c]furan-3,5a(6H)-diacetic acid, 6-tert-butyl-3a-carboxyhexahydro-α5a,1,2,3,5,8-hexahydroxy-α3-methyl-, tri-γ-lactone; Ginkgolide A, 1-hydroxy-, (1β)-; 9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)hexahydro-4,7b,11-trihydroxy-8-methyl-, [1R-(1α,3β,3aS*,4β,6aα,7aα,7bα,8α,10aα,11β,11aR*)]-; Bilobalide B; BN 52021; BN 52051; Ginkgolides, ginkgolide B. Grade: >98%. CAS No. 15291-77-7. Molecular formula: C20H24O10. Mole weight: 424.40. | |
| Ginkgolide B from Ginkgo biloba leaves | ?90% (HPLC). Group: Herbal medicinal products standards. | |
| Ginkgolide C | Ginkgolide C is a flavone isolated from Ginkgo biloba leaves, possessing multiple biological functions, such as decreasing platelet aggregation and ameliorating Alzheimer disease. Uses: Scientific research. Group: Natural products. Alternative Names: BN-52022. CAS No. 15291-76-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg. Product ID: HY-N0785. | |
| Ginkgolide C | Ginkgolide C is a bioactive diterpenoid trilactone compound derived from the leaves of the Ginkgo biloba tree. Similar to its counterparts Ginkgolide A and Ginkgolide B, it is characterized by its unique trilactone structure with multiple chiral centers, contributing to its diverse pharmacological properties. Ginkgolide C is known for its potent antagonistic effects on platelet-activating factor (PAF), making it a promising candidate for treating inflammatory and allergic conditions. Additionally, it has been studied for its neuroprotective effects, particularly in the context of neurodegenerative diseases and cerebral ischemia. Synonyms: (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-Dimethylethyl)hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-9H-1,7a-(epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione; 5H-Dicyclopenta[b,c]furan-3,5a(6H)-diacetic acid, 6-tert-butyl-3a-carboxyhexahydro-α5a,1,2,3,5,7,8-heptahydroxy-α3-methyl-, tri-γ-lactone; Ginkgolide A, 1,7-dihydroxy-, (1β,7β)-; 9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-, [1R-(1α,2α,3β,3aS*,4β,6aα,7aα,7bα,8α,10aα,11α,11aR*)]-; BN 52022. Grade: >98%. CAS No. 15291-76-6. Molecular formula: C20H24O11. Mole weigh | |
| Ginkgolide C | Family of bioactive terpenes treating cardiovascular and cerebrovascular diseases. Specific platelet activating factor (PAF) antagonists. Group: Biochemicals. Alternative Names: (1S, 2R, 3S, 3aS, 4R, 6aR, 7aR, 7bR, 8S, 10aS, 11R, 11aR) -3- (1, 1-Dimethylethyl) hexahydro-2, 4, 7b, 11-tetrahydroxy-8-methyl-9H-1, 7a- (epoxymethano) -1H, 6aH-cyclopenta[c]furo[2, 3-b]furo[3', 2': 3, 4]cyclopenta[1, 2-d]furan-5, 9, 12 (4H) -trione; BN 52022. Grades: Highly Purified. CAS No. 15291-76-6. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Ginkgolide J | analytical standard. Group: Natural compounds. | |
| Ginkgolide J | Ginkgolide J. Group: Biochemicals. Grades: Highly Purified. CAS No. 107438-79-9. Pack Sizes: 1mg, 2mg, 5mg, 10mg, 25mg. Molecular Formula: C20H24O10. US Biological Life Sciences. | Worldwide |
| Ginkgolide K | Ginkgolide K is extracted from the leaves of Ginkgo biloba L. It promotes angiogenesis after ischemia stroke and promotes astrocyte migration and proliferation after oxygen-glucose deprivation. It improves nerve injury after cerebral ischemia-reperfusion and inhibits PAF-induced platelet aggregation. It also can promote the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells and shows anti- Parkinson's disease activity. It shows neuroprotective effect and anti-oxidative stress on ischemic stroke. Synonyms: 9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-(1,1-dimethylethyl)-2,3,10a,11-tetrahydro-4,11-dihydroxy-8-methyl-, (1R,3S,3aS,4R,6aR,7aS,10aR,11R,11aR)-. Grade: 97.5%. CAS No. 153355-70-5. Molecular formula: C20H22O9. Mole weight: 406.38. | |
| Ginkgoneolic acid | Ginkgoneolic acid. Group: Biochemicals. CAS No. 20261-38-5. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Ginkgo terpene lactones | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Ginkgotoxin | analytical standard. Group: Herbal medicinal products standards. | |
| Ginseng extract | Ginseng extract. Applications: Functional food, health care products and pharmaceuticals. Group: Others. Purity: 8%-80.0% Ginsenoside. Appearance: Off white powder. Source: Ginseng is perhaps the most widely recognized plant used in traditional medicine and now plays a major role in the herbal health care market. For more than 2, 000 years, various forms have been used medicinally. The name Panax derives from the Greek word for"all healing, " and its properties have been so touted. Ginseng roots man-shaped figure (shen-seng means "man-root") led proponents of the doctrine of signatures, an ancient European herbalists philosophy, to believe that the root could strengthen any part of the body. Through the ages, the root has been used in the treatment of asthenia, atherosclerosis, blood and bleeding disorders, and colitis, as well as to relieve the effects of aging, cancer, and senility. Ginseng extract. Cat No: EXTC-184. | |
| Ginseng Extract | Ginseng Extract. Uses: Designed for use in research and industrial production. Product Category: Material of health food. Appearance: White powder. CAS No. 90045-38-8. Molecular formula: C15H24N2O. Mole weight: 248.37. Product ID: ACM90045388. Alfa Chemistry ISO 9001:2015 Certified. | |
| Ginseng Extract (Ratio) | Ginseng Extract (Ratio). Group: Others. Purity: 4:1~20:1. Ginseng Extract (Ratio). Cat No: EXTW-035. | |
| Ginseng Ginsenosides Mix | 100 ?g/mL each component in methanol, ampule of 100 ?g/mL, certified reference material. Group: Herbal medicinal products standards. | |
| Ginseng, Korean extract | Ginseng, Korean extract. Product ID: 10-0032. Properties: powder. |  |
| ginsenosidase type I | Ginsenosidase type I is slightly activated by Mg2+ or Ca2+. The enzyme hydrolyses the 3-O-β-D-(1?2)-glucosidic bond, the 3-O-β-D-glucopyranosyl bond and the 20-O-β-D-(1?6)-glycosidic bond of protopanaxadiol-type ginsenosides. It usually leaves a single glucosyl residue attached at position 20 and one or no glucosyl residues at position 3. Starting with a ginsenoside that is glycosylated at both positions (e.g. ginsenoside Rb1, Rb2, Rb3, Rc or Rd), the most common products are ginsenoside F2 and ginsenoside C-K, with low amounts of ginsenoside Rh2. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.193. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3877; ginsenosidase type I; EC 3.2.1.193. Cat No: EXWM-3877. | |
| ginsenosidase type III | Ginsenosidase type III catalyses the sequential hydrolysis of the 3-O-β-D-(1?2)-glucopyranosyl bond followed by hydrolysis of the 3-O-β-D-glucopyranosyl bond of protopanaxadiol ginsenosides. When acting for example on ginsenoside Rb1 the enzyme first generates ginsenoside XVII, and subsequently ginsenoside LXXV. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.191. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3875; ginsenosidase type III; EC 3.2.1.191. Cat No: EXWM-3875. | |
| ginsenosidase type IV | Ginsenosidase type IV catalyses the sequential hydrolysis of the 6-O-β-D-(1?2)-glycosidic bond or the 6-O-α-D-(1?2)-glycosidic bond in protopanaxatriol-type ginsenosides with a disacchride attached to the C6 position, followed by the hydrolysis of the remaining 6-O-β-D-glycosidic bond (e.g. ginsenoside Re ? ginsenoside Rg1 ? ginsenoside F1). Group: Enzymes. Enzyme Commission Number: EC 3.2.1.194. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3878; ginsenosidase type IV; EC 3.2.1.194. Cat No: EXWM-3878. | |
| Ginsenoside CK | Ginsenoside compound K (C-K) is a metabolite of the protopanaxadiol-type saponins of Panax ginseng C.A. Meyer (Araliaceae), has long been used to treat against the development of cancer, inflammation, allergies, and diabetes; C-K acts as a unique HUVEC migration inhibitor by regulating MMP expression, as well as the activity of SPHK1 and its related sphingolipid metabolites. [1]Ginsenoside compound K, the intestinal metabolite of ginseng saponin, has various chemopreventive and chemotherapeutic activities, including anti-tumor activity; C-K suppresses the activation of the NF-κB pathway, may become a potential cytotoxic drug in the prevention and treatment of hepatocellular carcinoma( HCC).[2]Ginsenoside compound K shows significant anti-proliferative effects and pro-apoptotic effects in HCT-116 and SW-480 cells at concentrations of 30-50 uM, suggests that C-K could be potentially effective anti-colorectal cancer agent.[3]Ginsenoside CK has anti-cancer effect on NPC cells, C-K-induced apoptosis of HK-1 cells was mediated by the mitochondrial pathway and could significantly inhibit tumor growth in vivo.[4]. Group: Biochemicals. Alternative Names: (3 β,12 β)-3,12-Dihydroxydammar-24-en-2. Grades: Highly Purified. CAS No. 39262-14-1. Pack Sizes: 10mg, 20mg, 50mg, 100mg. Molecular Formula: C??H??O?, Molecular Weight: 622.87. US Biological Life Sciences. | Worldwide |
| Ginsenoside C-K | Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 ?M and 63.6±4.2 ?M, respectively. Uses: Scientific research. Group: Natural products. Alternative Names: Ginsenoside compound K; Ginsenoside K. CAS No. 39262-14-1. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-N0904. | |
| Ginsenoside C-K | Ginsenoside C-K is an intestinal microbiota metabolite of ginsenoside Rb1, which possesses anti-proliferative and anti-inflammatory activities. Synonyms: Ginsenoside K. Grade: >98%. CAS No. 39262-14-1. Molecular formula: C36H62O8. Mole weight: 622.87. | |
| Ginsenoside Compound K | Ginsenoside Compound K. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Compound K; Ginsenoside K; X1141; N1890. Appearance: White powder. CAS No. 39262-14-1. Molecular formula: C36H62O8. Mole weight: 622.88. Purity: 0.98. IUPACName: (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. Canonical SMILES: CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C. Density: 1.19. Product ID: ACM39262141. Alfa Chemistry ISO 9001:2015 Certified. | |
| Ginsenoside F1 | Ginsenoside F1. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 3β,6α,12β-Trihydroxy-5α-dammar-24-en-20-yl β-D-glucopyranoside. Appearance: White powder. CAS No. 53963-43-2. Molecular formula: C36H62O9. Mole weight: 638.87. Purity: 0.98. IUPACName: (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol. Canonical SMILES: CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C. Density: 1.23±0.1 g/ml. Product ID: ACM53963432. Alfa Chemistry ISO 9001:2015 Certified. | |
| Ginsenoside F1 | Ginsenoside F1. Group: Biochemicals. Grades: Plant Grade. CAS No. 53963-43-2. Pack Sizes: 20mg. Molecular Formula: C36H62O9, Molecular Weight: 638.87. US Biological Life Sciences. | Worldwide |
| Ginsenoside F1 | Ginsenoside F1, an enzymatically modified derivative of Ginsenoside Rg1, demonstrates competitive inhibition of CYP3A4 activity and weaker inhibition of CYP2D6 activity. Uses: Scientific research. Group: Natural products. Alternative Names: 20(S)-Ginsenoside F1. CAS No. 53963-43-2. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 50 mg. Product ID: HY-N0598. | |
| Ginsenoside F1 | Ginsenoside F1, a metabolite of ginsenoside Rg1, is reported to be antiaging and antioxidative, and to have beneficial effects on skin. It significantly reduced ultraviolet-B-induced cell death and protected HaCaT cells from apoptosis caused by ultraviolet B irradiation. Uses: A metabolite of ginsenoside rg1. Synonyms: (20S)-20-(β-D-Glucopyranosyloxy)dammar-24-ene-3β,6α,12β-triol; 3β,6α,12β-Trihydroxy-5α-dammar-24-en-20-yl β-D-glucopyranoside; (3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside; 20(S)-Ginsenoside F1; Panaxoside Aprogenin. Grade: >98%. CAS No. 53963-43-2. Molecular formula: C36H62O9. Mole weight: 638.87. | |
| Ginsenoside F2 | Ginsenoside F2 is extracted from the root of Panax ginseng C. A. Mey. It was assessed for its antiproliferative activity against breast cancer stem cells (CSCs). It induced apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction. It decreased the expression of TGF-β2 and SCAP proteins. Synonyms: (20S)-3β,20-Bis(β-D-glucopyranosyloxy)-5α-dammar-24-ene-12β-ol; 12β-Hydroxy-5α-dammar-24-ene-3β,20-diylbis(β-D-glucopyranoside); 20(S)-Ginsenoside-F2. Grade: >98%. CAS No. 62025-49-4. Molecular formula: C42H72O13. Mole weight: 785.01. | |
| Ginsenoside F2 | Ginsenoside F2. Group: Biochemicals. Grades: Plant Grade. CAS No. 62025-49-4. Pack Sizes: 20mg. Molecular Formula: C42H72O13, Molecular Weight: 785.01. US Biological Life Sciences. | Worldwide |
| Ginsenoside F2 | Ginsenoside F2, a metabolite from Ginsenoside Rb1, induces apoptosis accompanied by protective autophagy in breast cancer stem cells [1]. Uses: Scientific research. Group: Natural products. CAS No. 62025-49-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 20 mg. Product ID: HY-125848. | |
| Ginsenoside F3 | Ginsenoside F3. Group: Biochemicals. Grades: Plant Grade. CAS No. 62025-50-7. Pack Sizes: 10mg. Molecular Formula: C41H70O13, Molecular Weight: 770.99. US Biological Life Sciences. | Worldwide |
| Ginsenoside F4 | Ginsenoside F4. Group: Biochemicals. Alternative Names: Δ20(22)-Ginsenoside Rg6. Grades: Plant Grade. CAS No. 181225-33-2. Pack Sizes: 5mg. Molecular Formula: C42H70O12, Molecular Weight: 766.998. US Biological Life Sciences. | Worldwide |
| Ginsenoside Mb | Ginsenoside Mb. Group: Biochemicals. CAS No. 88105-29-7. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Ginsenoside Rb1 | Ginsenoside Rb1, a main constituent of the root of Panax ginseng , inhibits Na + , K + -ATPase activity with an IC 50 of 6.3±1.0 μM. Ginsenoside also inhibits IRAK-1 activation and phosphorylation of NF-κB p65. Uses: Scientific research. Group: Natural products. Alternative Names: Gypenoside III. CAS No. 41753-43-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0039. | |
| Ginsenoside Rb1 | primary reference standard. Group: Natural compoundscarbohydrateseuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. | |
| Ginsenoside Rb1 | Ginsenoside Rb1. Group: Biochemicals. Alternative Names: Sanchinoside E1; Gypenoside III; Gynosaponin C. Grades: Plant Grade. CAS No. 41753-43-9. Pack Sizes: 20mg. Molecular Formula: C54H92O23, Molecular Weight: 1109.29. US Biological Life Sciences. | Worldwide |
| Ginsenoside Rb1 | A major bioactive component of panax ginseng that promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. It has been reported to display immunostimulatory and anticancer effects. It has anti-aging effect, can be used in health products. Uses: Anti-oxidative damage,immunostimulatory,anticancer. Synonyms: β-D-Glucopyranoside, (3β,12β)-20-[(6-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-; (3β,12β)-20-[(6-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside; Arasaponin E1; Gynosaponin C; Gypenoside III; Notoginsenoside Rb1; NSC 310103; Panaxoside Rb1; RB 1; Sanchinoside E1; Sanchinoside Rb1. Grade: ≥95%. CAS No. 41753-43-9. Molecular formula: C54H92O23. Mole weight: 1109.32. | |
| Ginsenoside Rb1 | Ginsenoside Rb1, a main constituent of the root of Panax ginseng, inhibits Na+, K+-ATPase activity with an IC50 of 6.3±1.0 μM. Ginsenoside also inhibits IRAK-1 activation and phosphorylation of NF-κB p65. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2-O-beta-glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside. Product Category: Inhibitors. Appearance: White powder. CAS No. 41753-43-9. Molecular formula: C54H92O23. Mole weight: 1109.29. Purity: 0.98. IUPACName: (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol. Canonical SMILES: CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C. Density: 1.097 g/ml. Product ID: ACM41753439. Alfa Chemistry ISO 9001:2015 Certified. | |
| ginsenoside Rb1 β-glucosidase | Ginsenosidases catalyse the hydrolysis of glycosyl moieties attached to the C-3, C-6 or C-20 position of ginsenosides. They are specific with respect to the nature of the glycosidic linkage, the position and the order in which the linkages are cleaved. Ginsenoside Rb1 β-glucosidase specifically and sequentially hydrolyses the 20-[β-D-glucopyranosyl-(1?6)-β-D glucopyranosyloxy] residues attached to position 20 by first hydrolysing the (1?6)-glucosidic bond to generate ginsenoside Rd as an intermediate, followed by hydrolysis of the remaining 20-O-β-D-glucosidic bond. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.192. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3876; ginsenoside Rb1 β-glucosidase; EC 3.2.1.192. Cat No: EXWM-3876. | |
| Ginsenoside Rb2 | Ginsenoside Rb2 is one of the main bioactive components of ginseng extracts. Rb2 can upregulate GPR120 gene expression. Ginsenoside Rb2 has antiviral effects. Uses: Designed for use in research and industrial production. Product Category: Inhibitors. Appearance: Cream-white powder. CAS No. 11021-13-9. Molecular formula: C53H90O22. Mole weight: 1079.27. Purity: 0.98. IUPACName: (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. Canonical SMILES: CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C. Product ID: ACM11021139. Alfa Chemistry ISO 9001:2015 Certified. Categories: Ginsenoside Rb1. | |
| Ginsenoside Rb2 | Ginsenoside Rb2 is a 20(S)-protopanaxadiol glycoside extracted from ginseng. It shows potent antioxidant and anticancer biological activities. It inhibited invasiveness to the basement membrane of endometrial cancer cell lines Ishikawa. Uses: Ginsenoside rb2 is extracted from ginseng and could inhibit the tumor growth and metastasis by destructing the angiogenesis. Synonyms: (3b,12b)-20-[(6-O-a-L-Arabinopyranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-(b-D-glucopyranosyl)-b-D-glucopyranoside; Ginsenoside C. Grade: >98%. CAS No. 11021-13-9. Molecular formula: C53H90O22. Mole weight: 1079.30. | |
| Ginsenoside Rb2 | Ginsenoside Rb2. Group: Biochemicals. Alternative Names: Ginsenoside. Grades: Plant Grade. CAS No. 11021-13-9. Pack Sizes: 20mg. Molecular Formula: C53H90O22, Molecular Weight: 1079.27. US Biological Life Sciences. | Worldwide |
| Ginsenoside Rb2 | Ginsenoside Rb2 is one of the main bioactive components of ginseng extracts. Rb2 can upregulate GPR120 gene expression. Ginsenoside Rb2 has antiviral effects. Uses: Scientific research. Group: Natural products. Alternative Names: Ginsenoside C. CAS No. 11021-13-9. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg. Product ID: HY-N0040. | |
| Ginsenoside Rb2 | analytical standard. Group: Herbal medicinal products standards. | |
Our database is helping our users find suppliers everyday.
